Acquired ERBB2 Amplification and Overexpression as On-Target Resistance Mechanisms to Zongertinib With Subsequent Response to Trastuzumab-Deruxtecan: A Case Report
获得性ERBB2扩增和过表达作为Zongertinib靶向耐药机制,随后对Trastuzumab-Deruxtecan产生反应:病例报告
期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2026.100960
McMahon, David John; John, Alexius; Kalofonou, Foteini; Amin, Nawa; Sarker, Sarah; Vick, Joanna; Yousaf, Nadia; Tokaca, Nadza; Robertus, JanLukas; MacMahon, Suzanne; Popat, Sanjay